Our team is heading to the ACC.24 for the first time to showcase our Al-powered interpretation platform, PMcardio. We’re eager to reconnect with the cardio community over in the US! Book a meeting with our team to catch up and discover more about PMcardio.
This session focuses on real life case studies, highlighting the diagnostic challenges in accurately identifying this life-threatening condition. This webinar is essential for healthcare professionals committed to adopting advanced techniques, including AI, to reduce missed or delayed diagnoses and improve patient outcomes in acute cardiac care.
Featuring experts Dr. Stephen W. Smith, Dr. H. Pendell Meyers, and Dr. Robert Herman, this webinar offered deep insights into the (Occlusion Myocardial Infarction) OMI Paradigm, demonstrating its superiority over traditional STEMI criteria in diagnosing Acute Coronary Syndrome (ACS).
Join us for an informative webinar about the diagnosis and management of Atrial Fibrillation in Primary Care. Our expert panelists will share their knowledge and practical tips on embracing innovation and applying the latest guidance in your day-to-day practice. We look forward to seeing you there!
Join us in an exciting, relevant and free webinar focused on ECG interpretation in primary care. Explore common scenarios, red-flag ECGs not to be missed, recognise abnormalities using AI technology. Designed to meet the needs of primary care clinicians, this session is both educational and practical, aiming to smooth the patient journey and referrals, reduce incorrect decisions, and foster trust.
Powerful Medical is redefining the landscape of medical diagnostics with its AI-driven solutions. The company’s certified PMcardio platform revolutionizes the way cardiovascular diseases are detected, offering rapid and accurate diagnostics that pave the way for timely and effective treatment.
PMcardio is CE-marked as class IIb medial device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region.
Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
PMcardio is CE-marked as class IIb medial device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region. Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
